生物可降解支架的临床应用进展

发布时间：2018-04-21 03:21

本文选题：评论 + 支架　；参考：《中国循环杂志》2017年03期

【摘要】：在过去的40年经皮冠状动脉介入治疗(PCI)策略在不断进展,新一代药物洗脱支架(DES)明显降低了支架内再狭窄,提高了临床疗效。但金属的永久存留、再狭窄、血栓和对患者心理上的影响,限制了其在部分病情复杂患者中的应用。生物可降解支架(BRS)是支架技术的一大进步,可以完全吸收恢复血管自身弹性、应变力、生理剪切力,是冠心病介入治疗领域的第四次革命,有可能解决上述问题。
[Abstract]:In the past 40 years, the strategy of percutaneous coronary intervention (PCI) has been developing, and the new generation of drug-eluting stents (DESs) have significantly reduced restenosis and improved the clinical efficacy. But permanent retention of metals, restenosis, thrombosis, and psychological effects on patients limit their use in some complex patients. Biodegradable scaffold (BRS) is a great progress in stent technology, which can completely absorb and restore vascular elasticity, strain and physiological shear force. It is the fourth revolution in the field of coronary intervention therapy, which may solve the above problems.
【作者单位】：中国医学科学院北京协和医学院国家心血管病中心阜外医院冠心病诊治中心;
【分类号】：R541.4

【相似文献】